Had a look at the figures in particular sales.
They have only recently employed a further 2 Business development managers(Salesman) in the last 3 months giving 3 in total. So will take time for the new Salesman to find their feet.
The bookings for hardware for the quarter Dec 23 was $308k which was up from $239k or 28% which was promising.
Qualified opportunities at Dec 23 was 347k compared to Sep 23 260k up 33% also promising.
New licences YTD Dec 23 - 510 YTD Sep 23- 470 up 8.5%.
Also in cashflow it was quoted -
"The reduction in operating expenses and growth in sales is expected to
generate a positive net cash flow ".
They have entered into the agreement with Morph Clinical to further expand product lines and obtained a loan facility from NAB so they are looking to the future.
Overall the next 3-6 months will tell how they are tracking especially in sales.
- Forums
- ASX - By Stock
- JTL
- Ann: December 2023 Quarterly Update and Appendix 4C
Ann: December 2023 Quarterly Update and Appendix 4C, page-7
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)